Destaques
Mortalidade por síndrome do Zika congênita – Estudo de coorte nacional no Brasil.
24 Fev, 2022 | 15:43hJejum do Ramadan: recomendações para pacientes com doença cardiovascular.
24 Fev, 2022 | 15:41hRamadan fasting: recommendations for patients with cardiovascular disease – Heart
Conteúdos relacionados:
WHO Interim Guidance: Safe Ramadan Practices in the Context of the COVID-19
Position Statement: Guidance for People with Types 1 and 2 Diabetes Who Fast During Ramadan
Diabetes and Ramadan: Practical guidelines
Comentário no Twitter
Ramadan fasting: recommendations for patients with cardiovascular diseasehttps://t.co/genOJm0Vu4 pic.twitter.com/9E3awbPcvB
— Heart_BMJ (@Heart_BMJ) July 26, 2021
Diretriz preliminar da USPSTF | Uso de estatina na prevenção primária de doença cardiovascular em adultos.
24 Fev, 2022 | 13:52hComentário: USPSTF Updates Guidance on Statins for Primary Prevention of CVD – HealthDay
Diretriz científica AHA | Estratégias para reduzir o cuidado cardiovascular de baixo valor.
24 Fev, 2022 | 13:51hComunicado de imprensa: Do you really need that test? New statement highlights need to reduce “low-value” heart care – American Heart Association
OMS/UNICEF | Mais da metade dos pais e das gestantes são expostos à agressiva propaganda de fórmulas lácteas.
24 Fev, 2022 | 13:49hComentário: Aggressive’ marketing of formula milk flouts code, warns WHO as it urges curbs – The Guardian
Comentário no Twitter
"We have been targeted with marketing from formula milk companies."
Over half of parents & pregnant women exposed to formula milk marketing, violating international standards and harming child health
-🆕 WHO, @UNICEF survey➡️ https://t.co/86Bf69PSeK#EndExploitativeMarketing pic.twitter.com/BuhQPgM3OX
— World Health Organization (WHO) (@WHO) February 22, 2022
OMS | As 16 “melhores compras” para enfrentar doenças não transmissíveis.
24 Fev, 2022 | 13:47hWHO: Here Are The 16 ‘Best Buys’ To Tackle Non-Communicable Diseases – Forbes
Relatório original: WHO Report | Saving lives, spending less: the case for investing in noncommunicable diseases.
Estudo randomizado | Dexmedetomidina sublingual reduz a agitação leve a moderada em pacientes com transtorno bipolar.
24 Fev, 2022 | 13:46hEffect of Sublingual Dexmedetomidine vs Placebo on Acute Agitation Associated With Bipolar Disorder: A Randomized Clinical Trial – JAMA (gratuito por tempo limitado)
Editorial: Sublingual Dexmedetomidine as a Potential New Treatment for Agitation – JAMA (gratuito por tempo limitado)
Comentário no Twitter
Randomized clinical trial found sublingual #dexmedetomidine at a dose of 180 μg or 120 μg reduced mild to moderate agitation in patients with #bipolar disorder. https://t.co/1VK2e15F7s pic.twitter.com/0oHw6eVMIP
— JAMA (@JAMA_current) February 22, 2022
Amplo estudo baseado em registro nos EUA sugere que tratamentos para infertilidade são associados com riscos aumentados de complicações gestacionais e vasculares.
24 Fev, 2022 | 13:43hComunicado de imprensa: Common infertility treatments may increase risks for pregnancy, vascular complications – American Heart Association
Comentário: Infertility treatments raise risk of heart and pregnancy complications, study finds – CNN
Atualização de prática clínica da AGA sobre suspensão de inibidores de bomba de prótons.
22 Fev, 2022 | 15:45hConteúdos relacionados:
Deprescribing proton pump inhibitors guideline
Review: Deprescribing Proton Pump Inhibitors